VANCOMYCIN RESISTANT ENTEROCOCCI INFECTION

Clinical trials for VANCOMYCIN RESISTANT ENTEROCOCCI INFECTION explained in plain language.

Never miss a new study

Get alerted when new VANCOMYCIN RESISTANT ENTEROCOCCI INFECTION trials appear

Sign up with your email to follow new studies for VANCOMYCIN RESISTANT ENTEROCOCCI INFECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Hospital trial aims to block deadly gut infection before it starts

Prevention Recruiting now

This study is testing if a liquid antibiotic called vancomycin, taken by mouth, can prevent dangerous C. diff infections in critically ill adults who are at high risk while in the hospital. Researchers will compare the drug to a placebo (inactive liquid) in 176 participants to se…

Matched conditions: VANCOMYCIN RESISTANT ENTEROCOCCI INFECTION

Phase: PHASE2, PHASE3 • Sponsor: Riverside University Health System Medical Center • Aim: Prevention

Last updated Mar 30, 2026 14:28 UTC

VANCOMYCIN RESISTANT ENTEROCOCCI INFECTION

Get alerted when new VANCOMYCIN RESISTANT ENTEROCOCCI INFECTION trials appear

Hospital trial aims to block deadly gut infection before it starts